NRX Pharmaceuticals's total assets for Q were $7.32M, a decrease of -63.07% from the previous quarter. NRXP total liabilities were $19.05M for the fiscal quarter, a -15.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.